Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04770311 · ClinicalTrials.gov registry record · NA
Childhood Obesity Microbiome Study
A NA study of Pediatric Obesity, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT04770311: Completed NA study of Pediatric Obesity, sponsored by Duke University.
NCT04770311 is a NA study of Pediatric Obesity that has completed, run by Duke University. The registered enrollment target is 33 participants, below the 229-participant average among 45 other Pediatric Obesity trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04770311, a NA study of Pediatric Obesity, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure the effectiveness of a microbiome diet using direct food provision on dietary quality and microbiome composition among children with obesity. This study proposes a pilot randomized, controlled clinical trial in children of a dietary intervention informed by microbiome science.
Primary Outcome
The investigators will use the DSQ, which is the 26-item Dietary Screener Questionnaire, that asks about the frequency of consumption in the past month of selected foods and drinks. The DSQ captures intakes of fruits and vegetables, dairy/calcium, added sugars, whole grains/fiber, red meat, and processed meat. The study team will be focusing on microbiome friendly food, such as whole grains a fiber rich foods.
Conditions Studied
Interventions
- BEHAVIORAL Microbiome friendly diet
Study Locations (1)
North Carolina
- Duke Healthy Lifestyles Roxboro Street - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-04-09 |
| Est. Completion | 2021-11-20 |
| Phase | NA |
What the finished NCT04770311 record still lists
NCT04770311 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 229-participant average among 45 other Pediatric Obesity trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Pediatric Obesity appearing as the primary indexed condition, and to 1 intervention - of which Microbiome friendly diet is the first listed.
NCT04770311 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04770311 about?
NCT04770311 is a clinical study titled "Childhood Obesity Microbiome Study". The purpose of this study is to measure the effectiveness of a microbiome diet using direct food provision on dietary quality and microbiome composition among children with obesity. This study proposes a pilot randomized, controlled clinical trial in children of a dietary intervention informed by mi...
What is the current status of trial NCT04770311?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-04-09. Estimated completion is 2021-11-20.
What conditions does trial NCT04770311 study?
This clinical trial studies the following conditions: Pediatric Obesity.
What interventions are being tested in trial NCT04770311?
The interventions under investigation include: Microbiome friendly diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT04770311?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04770311 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pediatric Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04770311's enrollment target sits among peer trials
33 38th of 45 higher than 8 of 45 other Pediatric Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pediatric Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mechanistic Study of Inspiratory Training in Childhood Asthma (MICA)
RECRUITING · NA
-
iAmHealthy Clinical Practice Guideline (CPG)
RECRUITING · NA
-
Monitoring Eating Across Locations (MEAL) - Timing, Intake, and Mealtime Evaluation (TIME)
RECRUITING · NA
-
Nutrition and Obesity in Under-Represented Populations: Food Insecurity Research to Advance Science and Improve Health
RECRUITING · NA
-
Growing Healthy Children and Families in Rural Arkansas
RECRUITING · NA
-
Time Limited Eating in Adolescents With Type 2 Diabetes (KT2D)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI